Medicare's AI Prior Authorization Trial Cuts Medical Services Fast
Medicare tested AI-driven prior authorization to curb waste, and the technology immediately reduced the volume of approved medical services.
Medicare has begun piloting artificial intelligence to handle prior authorization decisions, a move designed to identify and eliminate wasteful medical spending within the government health program. The experiment marks one of the federal program's most significant forays into automated clinical decision-making, with AI systems evaluating requests for patient care before services are rendered.
The immediate result of the AI-assisted review process was a notable drop in the volume of medical services approved, according to the report. Prior authorization has long been a contentious tool in American health care, requiring providers to seek insurer or program approval before delivering certain treatments, procedures, or prescriptions. Automating that gate-keeping function through AI appears to have sharpened its restricting effect.
Read more Trump Administration Plans to Roll Back Pregnancy Job Protections →
The findings raise pointed questions about whether AI-driven cost controls could inadvertently limit access to necessary care for Medicare beneficiaries, who are predominantly elderly or disabled. Patient advocates and clinicians have historically criticized prior authorization as a barrier to timely treatment, and the accelerated pace of AI decisions may intensify those concerns.
At the same time, program administrators framing the pilot as a waste-reduction tool argue that a significant share of prior authorization requests involve medically unnecessary services, and that faster automated review could also speed approvals for clearly appropriate care. The balance between efficiency and patient access is expected to remain a central tension as Medicare evaluates expanding the technology.
The pilot represents a broader national trend of health insurers and government payers integrating machine-learning tools into utilization management, a practice that has already drawn scrutiny from Congress and federal regulators. Continue reading at MarketWatch.com
